Insider trades

Marriott Tina, COO of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 23 sales on the open market. The latest trade was on 24/11/15.

Marriott Tina

President and COO
First filing
23/01/27
Trades
79 trades
Buys / sales
0 / 23
12-month net buying
No record
Last trade
24/11/15

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/10/2424/10/286,000 sh$6.31$37,860−1.1%
Open-market sale10b5-1 plan24/09/2624/09/306,000 sh$7.00$42,000−1.1%
Open-market sale10b5-1 plan24/08/2924/09/036,000 sh$7.56$45,360−1.1%
Open-market sale10b5-1 plan24/07/2524/07/296,000 sh$8.13$48,780−1.1%
Open-market sale10b5-1 plan24/06/2724/06/286,000 sh$7.22$43,320−1.1%
Open-market sale10b5-1 plan24/05/3024/06/033,000 sh$8.78$26,340−0.6%
Open-market sale10b5-1 plan24/04/2524/04/293,000 sh$7.67$23,010−0.5%
RXRX
Open-market sale10b5-1 plan24/03/2124/03/258,000 sh2 trades$10.75avg.$85,990.4−1.2%
Open-market sale10b5-1 plan24/02/2224/02/238,000 sh$14.90$119,200−1.2%
Open-market sale10b5-1 plan24/01/2524/01/298,000 sh$10.35$82,800−1.9%
Open-market sale10b5-1 plan23/12/2824/01/028,000 sh$10.58$84,640−1.9%
Open-market sale10b5-1 plan23/11/1623/11/173,000 sh$6.76$20,280−0.7%
Open-market sale10b5-1 plan23/10/2623/10/303,000 sh$5.63$16,890−0.7%
Open-market sale10b5-1 plan23/09/2823/10/023,000 sh$7.72$23,160−0.7%
RXRX
Open-market sale10b5-1 plan23/08/2423/08/283,000 sh2 trades$8.66avg.$25,971.03−0.7%
RXRX
Open-market sale10b5-1 plan23/07/2723/07/288,000 sh2 trades$13.63avg.$109,026.89−1.9%
Open-market sale10b5-1 plan23/06/2923/07/033,000 sh$7.49$22,470−0.7%
Open-market sale23/05/3123/06/023,000 sh$8.63$25,890−0.7%
Open-market sale23/02/2323/02/278,000 sh$7.82$62,560−1.8%
Open-market sale23/01/2623/01/278,000 sh$8.07$64,560−3.8%